CHAPTER 10 Reconstitution of Powdered Drugs

Similar documents
3. This solution retains potency for 2 8 hours at room temperature after reconstitution.

Mixing Methacholine Dilutions for Bronchoprovocation Challenge Testing

Dilution Sequence Protocol

Dilution Sequence Protocol

Dilution Sequence Protocol

TEV-TROPIN [somatropin (rdna origin) for injection] 5 mg & 10 mg

Aseptic Techniques. Techniques for Sterile Compounding. Pharmacy Technician Training Systems Passassured, LLC

APPENDIX 5. Donor Heart Perfusion & Preservation Protocol for NORS Teams in the UK

Note: Does have indication for Prophy- suggest 25 units/kg every other day

Lecture 24: PHARMACY CALCULATIONS for Technicians Preparing Intravenous Medications

Patients Guide for Self Administering Intravenous Antibiotics General points

RECOMBINATE. [Antihemophilic Factor (Recombinant)] (For intravenous use only)

Nursing Recruitment Practice Workbook

RECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS

RECONSTITUTION AND ADMINISTRATION INSTRUCTIONS FOR HEALTHCARE PROFESSIONALS. Hereditary Angioedema

USP <797> LABELING ESTABLISHING BEYOND-USE DATES AND IN-USE TIMES

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

Quantos Automated Dosing Solution Preparation Precise concentrations Process compliance Minimize out-of-specs

1.) Take an alcohol swab to the stopper of both your peptide vial and the vial of the dilutent.

CSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER

helping patients thrive Clotting Factor Concentrate Information

Provider Partners Pennsylvania Advantage Plan Offered by Provider Partners Health Plan April 2019 Formulary Addendum

Standard Test Procedures Manual

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

RayBio Human vwf ELISA Kit

CspB ELISA Kit DAS ELISA for the detection of CspB protein Catalog number: PSP 35500

extraction of EG and DEG from the matrix. However, the addition of all diluent at once resulted in poor recoveries.

Bt-Cry1Ac & Bt-Cry2A Multi-trait ELISA Kit DAS ELISA for the detection of Bt-Cry1Ac & Bt-Cry2A proteins Catalog number: PSM 14900

McGill University Health Center Pediatric Drug Infusion Preparation Chart

ON WATER DISPERSIBLE GRANULES (WG)

PreSens. Manual OxoPlate. OxoPlate OP96C. PreSens Precision Sensing

Technical Procedure for General Laboratory Equipment

The Decomposition of Potassium Chlorate

Soil Aggregate *Nominal Maximum Minimum Weight No. of Splits to Obtain Designation Sieve Size of Particle of Sample, Ibs Portion for Test

3 Solubility and Concentration

Multiplate Platelet Function Analyzer: An Overview

12mm Dissolved Oxygen Sensor Care and Use Instructions

SOLUBILITY OF A SOLID IN WATER

Name:. Correct Questions = Wrong Questions =.. Unattempt Questions = Marks =

TQC Bresle Chloride test 2008

CALCULATING SOLUTIONS AND DRUG DOSE RATES. % solution = (weight (g) 100) volume of solution (ml)

Math 081 Worksheet Section 5.4 v01 Spring 2011 Dressler. Name

Health Products Regulatory Authority

PACKAGE LEAFLET: INFORMATION FOR THE USER. Exembol Multidose 100 mg/ml concentrate for solution for infusion. Argatroban Monohydrate

See Important Reminder at the end of this policy for important regulatory and legal information.

Varithena Delivery System Instructions for Use INSTRUCTIONS FOR USE Please read the Product Monograph before using the product.

Bt-Cry2Ab and Bt-Cry3Bb1 Multi-trait ELISA Kit DAS ELISA for the detection of Bt-Cry2Ab and Bt-Cry3Bb1 proteins Catalog number: PSM 26800

Experiment C-6 Gas Solubility

Material Safety Data Sheet

MULTICHANNEL. Labnet International, Inc.

Before you start sampling, be sure to read

Varithena Delivery System Instructions for Use

Chemical Analysis for Methyltestosterone

MSD 96-Well MULTI-ARRAY Human (6E10) Abeta 42 Ultra-Sensitive Kit

MSD 96-Well MULTI-ARRAY Human (6E10) Abeta 40 Ultra-Sensitive Kit

PRODUCT SHEET. Order probe only as RXPROBE02

CORESTA RECOMMENDED METHOD Nº 67

IVIG Educational Presentation

TECHNICAL BULLETIN. TriControls. Control Materials for Liquid QC and Calibration Verification

Vinmetrica Dissolved Oxygen System User Manual

Antibiotic Treatments. Arthritis & Pain. Asthma. Cholesterol

OXYGEN CONSUMPTION AND TEMPERATURE IN THE AQUATIC ENVIRONMENT

Aerobic Respiration. Evaluation copy

Bante810 Benchtop Dissolved Oxygen Meter Instruction Manual

DRUG STABILITY AN EVIDENCE REVIEW AND DEVELOPMENT OF A NATIONAL METHODOLOGY FOR STABILITY TESTING OF AGENTS AND DEVICES

Material Safety Data Sheet for MAT Activity Assay Kit

SS32L Dissolved O 2 Probe

NSA Official Notices Tuesday, May 13, 2014

CHM250 Calibration and Measurement Lab. Balance Calibration

Clinical Mathematics

International Journal of Generic Drugs ANALYTICAL METHOD PROCEDURES THIS SOP IS 'SWITCHED : OFF : ON'

711 DISSOLUTION. Portions of the present general chapter text that are national USP text, and therefore not part of the

Clinical Mathematics

COMPOUNDING WITH HAZARDOUS DRUGS

Chemistry. TEKS 2D Organize, analyze, evaluate, make inferences, and predict trends from data.

SAFETY DATA SHEET. Version: 1.0

ul tive Review for Chapters 7 and 8 Concepts and Skills Write each fraction or mixed number as a decimal. (Lesson 7.1)

ASTM 3612/TOGA/Dissolved Gas GC Revised October 2013

Haldol lactate vs haldol decanoate

Ocular Irritation: Dilution Method

US - OSHA SAFETY DATA SHEET

Material safety data sheet According to the Regulation (EC) No: 1907/2006

Version: 2.0. Not established Sterile diluent for reconstitution of Marek s disease vaccine Mixture

product ospa lithium focus

LIGHTHOUSE. Stopper Pop-Up and the Effects on. Container Closure of Sterile Vials. Application Note 101 LIGHTHOUSE

Aseptic processing. the starting material to the finished product, should be controlled by Validation Control of the aseptic process

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Quantitative Analysis of Hydrocarbons by Gas Chromatography

Assisting with Insertion. Care of Intraspinal Catheters

QAM-I-117 Volumetric Equipment Calibration Verification

Clinician Guide. Baxter Elastomeric Devices. Promoting patient-centric care

A SIMPLE TITRATION METHOD FOR DETERMINING THE SPECIFIC GRAVITY ON ONE DROP OF URINE

1. PRODUCT IDENTIFICATION 2. COMPOSITION / INFORMATION ON HAZARDOUS INGREDIENTS

DOscan10 Pocket Dissolved Oxygen Tester Instruction Manual

Gastrostomy Tubes. Information for Parents and Carers

SAFETY DATA SHEET Version: 3.0

Name:. Correct Questions = Wrong Questions =.. Unattempt Questions = Marks =

Ophthalmic Special Order Products, General Principles

Name: Class: Date: SHORT ANSWER Answer the following questions in the space provided.

SOLUBILITY OF A SOLID IN WATER

Transcription:

CHAPTER 10 RECONSTITUTION OF POWDERED DRUGS 89 CHAPTER 10 Reconstitution of Powdered Drugs Objectives The learner will: 1. prepare solutions from powdered drugs using directions printed on vial labels. 2. prepare solutions from powdered drugs using drug literature or inserts. 3. determine the expiration date and time for reconstituted drugs. 4. calculate dosages for reconstituted drugs. Suggested Review Questions 1. Why are some drugs packaged in powdered form? 2. List the steps used when reconstituting a drug supplied in powdered form. 3. What information needs to be written on the drug label when the drug is a multiple strength solution? 4. Ask learners this question: You need to administer a drug supplied in powdered form; however, the type and amount of diluent needed to reconstitute the drug are not noted on the label. Where would you look for this information? Answers to Review Questions 1. Drugs that are packaged in powdered form need to be reconstituted prior to administration because they retain potency only a short time in solution. Stress the importance of reading labels to determine the amount of time a drug is stable in solution and the need to use that information when planning for drug administration. 2. The steps for reconstituting a drug supplied in powdered form are a. Determine the type and volume of diluent needed. b. Choose the appropriate sterile syringe to use when drawing up the diluent and injecting it into the medication vial. c. Use aseptic technique to draw up the specified amount of diluent and inject it into the medication vial.

90 SECTION 3 READING MEDICATION LABELS AND SYRINGE CALIBRATIONS d. Roll the vial in your hands to dissolve all the powder (emphasize not to shake the vial). e. Label vial with your initials (the person who did the reconstitution) and the expiration date and time. f. Store reconstituted medication according to label directions. 3. The essential information that needs to be written on the label of a multiple solution drug is the initials of the individual who reconstituted the drug, the dosage strength of the mixture, and the expiration date and time. 4. When not noted on the drug label, the preparation and stability information for a particular drug can be found on the package insert.

CHAPTER 10 RECONSTITUTION OF POWDERED DRUGS 91 Name Date Chapter 10: Reconstitution of Powdered Drugs Additional Practice Problems Refer to the medication labels below and determine the amount and type of diluent needed to reconstitute the drug, the amount of reconstituted drug needed to deliver the ordered dose (calculate to nearest 10th), the correct method for storage of the reconstituted drug, and the length of time the reconstituted drug will retain potency. 1. a. Dose: Solu-Medrol 250 mg b. Type of diluent c. Amount of diluent d. Storage method e. Will retain potency Used with permission from Pfizer Inc. f. Other special instructions 2. a. Dose: cytarabine 150 mg b. Type of diluent c. Amount of diluent d. Storage method e. Will retain potency Used with permission from Bedford Laboratories, A Division of Ben Venue Laboratories Inc. A Boehringer-Ingelheim Company. 3. Nafcillin 500 mg has been ordered. Nafcillin is supplied as a powder in a vial. The directions on the vial label state reconstitute with 6.6 ml of normal saline. Each ml will contain 250 mg of nafcillin. 2010 Cengage Learning. All Rights Reserved. Permission to reproduce granted for classroom use only.

92 SECTION 3 READING MEDICATION LABELS AND SYRINGE CALIBRATIONS 4. Cefazolin 500 mg is ordered. Cefazolin is supplied as a powder in a vial. Directions on the vial state add 10 ml of sterile water for injection for a concentration of 100 mg/ml. 5. Ticarcillin 700 mg is ordered. Ticarcillin is supplied as a powder in a vial. Directions on the vial state add 2 ml of sterile water for injection. Each 2.6 ml of solution will contain 1 gram of ticarcillin. 6. Penicillin Potassium V 125 mg oral suspension is ordered. Penicillin Potassium V is supplied as a powder in a screw-top bottle. Directions on the bottle state fill with 75 ml of water and shake to mix completely. Each 5 ml of solution contains 250 mg of Penicillin Potassium V. 7. Levothyroxine 100 mcg has been ordered. The vial of levothyroxine states reconstitute with 5 ml of 0.9% sodium chloride injection. Once reconstituted, the concentration of levothyroxine is 40 mcg/ml. 8. Voriconazole 150 mg is ordered. Voriconazole is supplied as a powder in a vial. Directions on the label state reconstitute with 19 ml of sterile water for injection to obtain a solution containing 10 mg/ml. 9. 250 mg Vantin oral suspension is ordered. Vantin is supplied as a powder in a screw-top bottle. Directions on the label state add 29 ml water and shake to mix thoroughly. Once reconstituted, each 5 ml will contain 100 mg of Vantin. 10. Zithromax 200 mg has been ordered. Zithromax is supplied as a powder in a vial. Directions on the vial state reconstitute with 4.8 ml of sterile water for injection. Each ml of solution contains 100 mg of drug. 2010 Cengage Learning. All Rights Reserved. Permission to reproduce granted for classroom use only.

CHAPTER 10 RECONSTITUTION OF POWDERED DRUGS 93 Solutions to Additional Practice Problems 1. a. 4 ml: When reconstituted, there is 500 mg in 8 ml; 250 mg is needed which is half of total mg, thus half of total volume. b. bacteriostatic water for injection c. 8 ml d. controlled room temperature 20 to 25 C; 68 to 77 F e. 48 hours after reconstitution f. protect from light 2. a. 3 ml: Label states that once reconstituted, each ml contains 50 mg of medication. Therefore, if there is 50 mg in 1 ml, 3 ml are needed for 150 mg. b. bacteriostatic water for injection c. 10 ml d. controlled room tempurature 15 to 30 C; 59 to 86 F e. 48 hours 3. 2 ml is needed. 500 mg is ordered. There is 250 mg per ml, therefore, 2 ml is needed. 4. 5 ml is needed. 500 mg is ordered, and the concentration of drug is 100 mg/ml. A fraction depicting the ratio needed given what is supplied can be formed: 500 mg/ 100 mg/ml = 5 ml. 5. 1.8 ml is needed. 700 mg is ordered, and the concentration of drug is 1 g or 1000 mg/ 2.6 ml. A fraction depicting the ratio needed given what is supplied can be formed: 700 mg/1000 mg/ml = 0.7 ml = total volume needed. To solve for volume multiply 0.7 2.6 = 1.82 = 1.8 ml when rounded to nearest tenth. 6. 2.5 ml is needed. 125 mg is ordered, and the concentration of drug is 250 mg/5ml. 125 mg is half of 250 mg, therefore, half of 5 ml is 2.5 ml. 7. 2.5 ml is needed. 100 mcg is ordered, and the concentration of drug is 40 mcg/ml. A fraction depicting the ratio needed given what is supplied can be formed: 100 mcg/ 40 mcg/ml = 2.5 ml.

94 SECTION 3 READING MEDICATION LABELS AND SYRINGE CALIBRATIONS 8. 15 ml is needed. 150 mg is ordered, and the concentration of drug is 10 mg/ml. A fraction depicting the ratio needed given what is supplied can be formed: 150 mg/ 10 mg/ml = 15 ml. 9. 12.5 ml is needed. 250 mg is ordered, and the concentration of drug is 100 mg/5 ml or each ml would contain 20 mg. A fraction depicting the ratio needed given what is supplied can be formed: 250 mg/20 mg/ml = 12.5 ml. 10. 2 ml is needed. 200 mg is ordered, and the concentration of drug is 100 mg/ml. A fraction depicting the ratio needed given what is supplied can be formed: 200 mg/ 100 mg/ml = 2 ml.